Bayer aims to help CureVac with COVID-19 vaccine output, says CEO
German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday.
German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday.
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company’s branded and specialty drugs that dragged sales…
Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in…
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic.
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company’s branded and specialty drugs that dragged sales…
Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss its experimental Alzheimer’s disease drug, donanemab, on June 10.
Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in…
A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer’s experimental gene therapy for a muscle-wasting disorder called Duchenne…
Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid vaccine worldwide, The Telegraph reported on Tuesday.
Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it…